Cardiovascular (CV)-Related Hospitalizations and Associated Costs Among US Patients in Simplicity: An Observational Study of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) in Routine Clinical Practice

被引：0
|
作者：
Goldberg, Stuart L. [1 ]
Mauro, Michael J. [2 ]
Cortes, Jorge E. [3 ]
Keating, Scott Justin [4 ]
Bhandari, Hitesh [5 ]
Chen, Clara [4 ]
机构：
[1] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA
[2] Mem Sloan Kettering Canc Ctr, Myeloproliferat Neoplasms Program, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[4] Bristol Myers Squibb, Princeton, NJ USA
[5] SmartAnalyst India Pvt Ltd, Gurgaon, India
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-128290
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4151
引用
收藏
页数：3
相关论文
共 50 条
  • [1] CARDIOVASCULAR (CV)-RELATED HOSPITALIZATION IN PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) IN SIMPLICITY, A PROSPECTIVE OBSERVATIONAL STUDY
    Paquette, R.
    Mauro, M.
    Simonsson, B.
    Abruzzese, E.
    Andorksy, D.
    Hansen, R.
    Subar, M.
    Turner, M.
    Zyczynski, T.
    Mohamed, H.
    Goldberg, S. L.
    HAEMATOLOGICA, 2015, 100 : 437 - 437
  • [2] Cardiovascular Hospitalization in Patients Treated with Dasatinib or Nilotinib in Simplicity, an Observational Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients in Routine Clinical Practice
    Mauro, Michael J.
    Chen, Clara
    Cortes, Jorge E.
    Gambacorti-Passerini, Carlo
    Sen, Ginny P.
    Gajavelli, Srikanth
    Davis, Catherine
    Michallet, Mauricette
    BLOOD, 2018, 132
  • [3] Incidence of Cardiovascular (CV)-Related Hospitalizations and Associated Costs Among US Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated with First-Line (1L) Tyrosine Kinase Inhibitors (TKI) in SIMPLICITY: An Observational Study
    Goldberg, Stuart L.
    Mauro, Michael
    Cortes, Jorge
    Keating, Scott J.
    Bhandari, Hitesh
    Chen, Clara
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S241 - S242
  • [4] Cytogenetic and Molecular Responses in Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) in a Prospective Observational Study (SIMPLICITY)
    Mauro, Michael
    Gambacorti-Passerini, Carlo
    Goldberg, Stuart L.
    Cortes, Jorge E.
    Khoury, H. Jean
    Michallet, Mauricette
    Paquette, Ronald
    Simonsson, Bengt
    Turner, Michelle P.
    Mohamed, Hesham
    Subar, Milayna
    Zyczynski, Teresa
    BLOOD, 2014, 124 (21)
  • [5] Cytogenetic and molecular responses in German patients with chronic-phase chronic myeloid leukemia (CP-CML) in a prospective observational study (SIMPLICITY)
    Repp, R.
    Hehlmann, R.
    Linde, H.
    Reiser, M.
    Tesch, H.
    Foreman, A.
    Schreiner, L.
    Hillig, G.
    Oncology Research and Treatment, 2015, 38 : 132 - 132
  • [6] TYROSINE KINASE INHIBITOR (TKI) SWITCHING: EXPERIENCE FROM SIMPLICITY, A PROSPECTIVE OBSERVATIONAL STUDY OF CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS IN CLINICAL PRACTICE
    Hehlmann, R.
    Cortes, J.
    Gambacorti-Passerini, C.
    Goldberg, S. L.
    Khoury, H. J.
    Mauro, M.
    Michallet, M.
    Mohamed, H.
    Powell, T.
    Paquette, R.
    Simonsson, B.
    Subar, M.
    Zyczynski, T.
    HAEMATOLOGICA, 2014, 99 : 328 - 329
  • [7] 30Dosing Patterns of Dasatinib Use in Simplicity, an Observational Study in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients (pts) in Routine Clinical Practice
    Cortes, Jorge E.
    Chen, Clara
    Mauro, Michael J.
    Sen, Ginny P.
    Gajavelli, Srikanth
    Davis, Catherine
    Goldberg, Stuart L.
    BLOOD, 2018, 132
  • [8] IMATINIB DISCONTINUATION AND TKI SWITCHING PATTERNS IN THE RETROSPECTIVE AND PROSPECTIVE COHORTS IN SIMPLICITY, A STUDY OF CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS (PTS) IN ROUTINE CLINICAL PRACTICE
    Zyczynski, T.
    Khoury, J.
    Goldberg, S.
    Mauro, M.
    Michallet, M.
    Paquette, R.
    Foreman, A.
    Subar, M.
    Turner, M.
    Daumont, Manley M.
    Hehlmann, R.
    Simonsson, B.
    VALUE IN HEALTH, 2016, 19 (07) : A894 - A895
  • [9] Tyrosine Kinase Inhibitor (TKI) Switching Patterns during the First 12 Months in Simplicity, an Observational Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients (Pts) in Routine Clinical Practice
    Goldberg, Stuart
    Michallet, Mauricette
    Hehlmann, Rudiger
    Zyczynski, Teresa
    Foreman, Aimee
    Calimlim, Brian
    Paquette, Ron
    Simonsson, Bengt
    Gambacorti, Carlo
    Cortes, Jorge E.
    Zagorska, Aleksandra
    Rong, Yuanxin
    Mauro, Michael J.
    BLOOD, 2016, 128 (22)
  • [10] Cytogenetic and Molecular Responses after 2 Years of Tyrosine Kinase Inhibitor (TKI) Treatment in Simplicity, an Observational Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients (Pts) in Routine Clinical Practice
    Cortes, Jorge E.
    Goldberg, Stuart L.
    Michallet, Mauricette
    Hehlmann, Rudiger
    Simonsson, Bengt
    Mauro, Michael J.
    Williams, Loretta A.
    Zyczynski, Teresa
    Sen, Ginny P.
    Foreman, Aimee
    Gajavelli, Srikanth
    Gambacorti-Passerini, Carlo
    BLOOD, 2017, 130
12345